Joseph C. Scodari

Biography

Joseph C. Scodari has served as Chairman of the Optinose Board of Directors since October 2017. Mr. Scodari was Worldwide Chairman, Pharmaceuticals Group, of Johnson & Johnson, and a member of Johnson & Johnson’s Executive Committee. He also served as Company Group Chairman of Johnson & Johnson’s Biopharmaceutical Business. Mr. Scodari joined Johnson & Johnson in 1999 as President of Centocor, when Johnson & Johnson acquired that company. Prior to Johnson & Johnson, he served as Centocor’s President, Pharmaceutical Division, and was later named President and Chief Operating Officer. Mr. Scodari began his career in 1974 in sales for Winthrop Laboratories, a division of Sterling Drug. He progressed through various management positions, eventually leading the Diagnostic Imaging Division for Winthrop and later Strategic Marketing at the Corporate level for the imaging business. Mr. Scodari joined Rorer Pharmaceuticals (shortly thereafter, Rhône-Poulenc Rorer) in 1989 as Vice President of Marketing and Business Development. He later served as Vice President and General Manager for the United States and subsequently North America, and finally as Senior Vice President and General Manager for the Americas. Mr. Scodari previously served as a director of Actelion Pharmaceuticals, Endo Health Solutions and Covance. Mr. Scodari served on various nonprofit boards, including the University of the Health Sciences in Philadelphia, the Board of Overseers for the Robert Wood Johnson School of Medicine and the Board of Trustees for Gwynedd Mercy College. He also served on various industry association boards including the NWDA Associate Member Board, the National Pharmaceutical Council, as Vice Chairman of the Biotechnology Industry Organization (BIO), and as Chairman of PA BIO. Mr. Scodari received a BA from Youngstown State University.  

Research Interest

Pharmaceuticals